Infect Control Hosp Epidemiol. 2021 Apr 16:1-4. doi: 10.1017/ice.2020.1412. Online ahead of print.
We performed secondary analyses of a postdischarge decolonization trial of MRSA carriers that reduced MRSA infection and hospitalization by 30%. Hospitalized MRSA infection was associated with 7.9 days of non-MRSA antibiotics and CDI in 3.9%. Preventing MRSA infection and associated hospitalization may reduce antibiotic use and CDI incidence.